Victory Capital Management
COCP icon

Victory Capital Management’s Cocrystal Pharma COCP Stock Holding History

Victory Capital Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,050
Closed -$5K – 2710
2022
Q2 		$5K Sell
1,050
-7
-0.7% -$37 ﹤0.01% 2677
2022
Q1 		$6K Sell
1,057
-30
-3% -$199 ﹤0.01% 2699
2021
Q4 		$8K Sell
1,087
-34
-3% -$348 ﹤0.01% 2737
2021
Q3 		$14K Sell
1,121
-57
-5% -$754 ﹤0.01% 2743
2021
Q2 		$18K Buy
+1,178
New +$17.9K ﹤0.01% 2712
2020
Q2 		– Sell
-963
Closed -$8K – 2671
2020
Q1 		$8K Buy
+963
New +$9.07K ﹤0.01% 3355
2019
Q4 		– Sell
-196
Closed -$5K – 2769
2019
Q3 		$5K Buy
+196
New +$5.08K ﹤0.01% 3446

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management's COCP Position: Q3 2022 in Review

Victory Capital Management sold out of Cocrystal Pharma (COCP) in Q3 2022, closing a stake of 1,050 shares — an estimated $5K sold.

Victory Capital Management first reported a position in COCP in Q3 2019 and held it in 7 quarters. The position peaked at $18K in Q2 2021. 27 funds tracked by Wall St. Rank hold COCP as of Q3 2022.

  • Victory Capital Management reported no remaining Cocrystal Pharma position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 1,050 Cocrystal Pharma shares in Q3 2022, an estimated $5K.
  • Victory Capital Management first reported a position in Cocrystal Pharma in Q3 2019 and held it in 7 quarters.
  • Victory Capital Management's Cocrystal Pharma position peaked at $18K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.